Why are US Clinical Trials so Expensive?
Dave Ricks, CEO of Eli Lilly, speaking on the excellent Cheeky Pint Podcast (hosted by John Collison, sometimes joined by Patrick as in this episode) had the clearest discussion of why US clinical trial costs are so expensive that I have read.
One point is obvious once you hear it: Sponsors must provide high-end care to trial participants–thus because U.S. health care is expensive, US clinical trials are expensive. Clinical trial costs are lower in other countries because health care costs are lower in other countries but a surprising consequence is that it’s also easier to recruit patients in other countries because sponsors can offer them care that’s clearly better than what they normally receive. In the US, baseline care is already so good, at least at major hospital centers where you want to run clinical trials, that it’s more difficult to recruit patients. Add in IRB friction and other recruitment problems, and U.S. trial costs climb fast.
Patrick
I looked at the numbers. So, apparently the median clinical trial enrollee now costs $40,000. The median US wage is $60,000, so we’re talking two thirds. Why and why couldn’t it be a 10th or a hundredth of what it is?David (00:10:50):
Yeah, brilliant question and one we’ve spent a lot of time working on…“Why does a trial cost so much?” Well, we’re taking the sickest slice of the healthcare system that are costing the most. And we’re ingesting them. We’re taking them out of the healthcare system and putting them in a clinical trial. Typically we pay for all care. So we are literally running the healthcare system for those individuals and that is in some ways for control, because you want to have the best standard of care so your experiment is properly conducted and it’s not just left to the whims of hundreds of individual doctors and people in Ireland versus the US getting different background therapies. So you standardize that, that costs money because sort of leveling up a lot of things, but then also in some ways you’re paying a premium to both get the treating physicians and have great care to get the patient. We don’t offer them remuneration, but they get great care and inducement to be in the study because you’re subjecting yourself quite often, not all the case, but to something other than the standard of care, either placebo or this. Or, in more specialized care, often it’s standard care plus X where X could actually be doing harm, not good. So people have to go into that in a blinded way and I guess the consideration is you’ll get the best care.Patrick (00:12:51):
Of the $40,000. How much of that should I look at as inducement and encouragement for the patient and how much should I look at it as the cost of doing things given the regulatory apparatus that exists?David (00:13:02):
The patient part is the level up part and I would say 20, 30% of the cost of studies typically would be this. So you’re buying the best standard of care, you’re not getting something less. That’s medicine costs, you’re getting more testing, you’re getting more visits, and then there is a premium that goes to institutions, not usually to the physician, the institution to pay for the time of everybody involved in it plus something. We read a lot about it in the NIH cuts, the 60% Harvard markup or whatever. There’s something like that in all clinical trials too. Overhead coverage, whatnot. But it’s paying for things that aren’t in the trial.Patrick (00:13:40):
US healthcare is famously the most expensive in the world. Yes. Do you run trials outside the US?David (00:13:44):
Yeah, actually most. I mean we want to actually do more in the US. This is a problem I think for our country. Take cancer care where you think, okay, what’s the one thing the US system’s really good at? If I had cancer, I’d come to the US, that’s definitely true. But only 4% of patients who have cancer in the US are in clinical trials. Whereas in Spain and Australia it’s over 25%.And some of that is because they’ve optimized the system so it’s easier to run and then enroll, which I’d like to get to, people in the trials. But some of it is also that the background of care isn’t as good. So that level up inducement is better for the patient and the physician. Here, the standard’s pretty good, so people are like, “Do I want to do something where there’s extra visits and travel time?” There’s another problem in the US which is, we have really good standards of care but also quite different performing systems and we often want to place our trials in the best performing systems that are famous, like MD Anderson or the Brigham. And those are the most congested with trials and therefore they’re the slowest and most expensive. So there’s a bit of a competition for place that goes on as well.
But overall, I would say in our diabetes and cardiovascular trials, many, many more patients are in our trials outside the US than in and that really shouldn’t be other than cost of the system. And to some degree the tuning of the system, like I mentioned with Spain and Australia toward doing more clinical trials. For instance, here in the US, everywhere you get ethics clearance, we call it IRB. The US has a decentralized system, so you have to go to every system you’re doing a study in. Some countries like Australia have a single system, so you just have one stop and then the whole country is available to recruit those types of things.
Patrick (00:15:31):
You said you want to talk about enrollment?David (00:15:32):
Yeah, yeah. It’s fascinating. So drug development time in the industry is about 10 years in the clinic, a little less right now. We’re running a little less than seven at Lilly, so that’s the optimization I spoke about. But actually, half of that seven is we have a protocol open, that means it’s an experiment we want to run. We have sites trained, they’re waiting for patients to walk in their door and to propose, “Would you like to be in the study?” But we don’t have enough people in the study. So you’re in the serial process, diffuse serial process, waiting for people to show up. You think, “Wow, that seems like we could do better than that. If Taylor Swift can sell at a concert in a few seconds, why can’t I fill an Alzheimer’s study? There seem to be lots of patients.” But that’s healthcare. It’s very tough. We’ve done some interesting things recently to work around that. One thing that’s an idea that partially works now is culling existing databases and contacting patients.Patrick (00:16:27):
Proactive outreach.
See also Chertman and Teslo at IFP who have a lot of excellent material on clinical trial abundance.
Lots of other interesting material in this episode including how Eli Lilly Direct—driven largely by Zepbound—has quickly become a huge pharmacy. The direct-to-consumer model it represents could be highly productive as more drugs for preventing disease are developed. I am not as anti-PBM as Ricks and almost everyone in the industry are but I will leave that for another day.
Here is the Cheeky Pint Podcast main page.
Waymo
Waymo now does highways in the Bay area.
Expanding our service territory in the Bay Area and introducing freeways is built on real-world performance and millions of miles logged on freeways, skillfully handling highway dynamics with our employees and guests in Phoenix, San Francisco, and Los Angeles. This experience, reinforced by comprehensive testing as well as extensive operational preparation, supports the delivery of a safe and reliable service.
The future is happening fast.
UCSD Faculty Sound Alarm on Declining Student Skills
The UC San Diego Senate Report on Admissions documents a sharp decline in students’ math and reading skills—a warning that has been sounded before, but this time it’s coming from within the building.
At our campus, the picture is truly troubling. Between 2020 and 2025, the number of freshmen whose math placement exam results indicate they do not meet middle school standards grew nearly thirtyfold, despite almost all of these students having taken beyond the minimum UCOP required math curriculum, and many with high grades. In the 2025 incoming class, this group constitutes roughly one-eighth of our entire entering cohort. A similarly large share of students must take additional writing courses to reach the level expected of high school graduates, though this is a figure that has not varied much over the same time span.
Moreover, weaknesses in math and language tend to be more related in recent years. In 2024, two out of five students with severe deficiencies in math also required remedial writing instruction. Conversely, one in four students with inadequate writing skills also needed additional math preparation.

The math department created a remedial course, only to be so stunned by how little the students knew that the class had to be redesigned to cover material normally taught in grades 1 through 8.
Alarmingly, the instructors running the 2023-2024 Math 2 courses observed a marked change in the skill gaps compared to prior years. While Math 2 was designed in 2016 to remediate missing high school math knowledge, now most students had knowledge gaps that went back much further, to middle and even elementary school. To address the large number of underprepared students, the Mathematics Department redesigned Math 2 for Fall 2024 to focus entirely on elementary and middle school Common Core math subjects (grades 1-8), and introduced a new course, Math 3B, so as to cover missing high-school common core math subjects (Algebra I, Geometry, Algebra II or Math I, II, III; grades 9-11).
In Fall 2024, the numbers of students placing into Math 2 and 3B surged further, with over 900 students in the combined Math 2 and 3B population, representing an alarming 12.5% of the incoming first-year class (compared to under 1% of the first-year students testing into these courses prior to 2021)
(The figure gives some examples of remedial class material and the percentage of remedial students getting the answers correct.)
The report attributes the decline to several factors: the pandemic, the elimination of standardized testing—which has forced UCSD to rely on increasingly inflated and therefore useless high school grades—and political pressure from state lawmakers to admit more “low-income students and students from underrepresented minority groups.”
…This situation goes to the heart of the present conundrum: in order to holistically admit a diverse and representative class, we need to admit students who may be at a higher risk of not succeeding (e.g. with lower retention rates, higher DFW rates, and longer time-to-degree).
The report exposes a hard truth: expanding access without preserving standards risks the very idea of a higher education. Can the cultivation of excellence survive an egalitarian world?
One-Third of US Families Earn Over $150,000
It’s astonishing that the richest country in world history could convince itself that it was plundered by immigrants and trade. Truly astonishing.
From Jeremy Horpedahl who notes:
This is from the latest Census release of CPS ASEC data, updated through 2024 (see Table F-23 at this link).
In 1967, only 5 percent of US families earned over $150,000 (inflation adjusted).

And even though it says so in the chart and in the text let me say it again, this is inflation adjusted and so yes it’s real and no the fact that housing has gone up in price doesn’t negate this, it’s built in. We would have done even better had NIMBYs not reduced the supply of housing.
See also Asness and Strain.
Addendum: Note it isn’t the rise of dual-earner households which haven’t increased for over 30 years.
European Stagnation
Excellent piece by Luis Garicano, Bengt Holmström & Nicolas Petit.

The continent faces two options. By the middle of this century, it could follow the path of Argentina: its enormous prosperity a distant memory; its welfare states bankrupt and its pensions unpayable; its politics stuck between extremes that mortgage the future to save themselves in the present; and its brightest gone for opportunities elsewhere. In fact, it would have an even worse hand than Argentina, as it has enemies keen to carve it up by force and a population that would be older than Argentina’s is today.
Or it could return to the dynamics of the trente glorieuses. Rather than aspire to be a museum-cum-retirement home, happy to leave the technological frontier to other countries, Europe could be the engine of a new industrial revolution. Europe was at the cutting edge of innovation in the lifetime of most Europeans alive today. It could again be a continent of builders, traders and inventors who seek opportunity in the world’s second largest market.
The European Union does not need a new treaty or powers. It just needs a single-minded focus on one goal: economic prosperity.
I’ve quoted the call to arms but there is much more substantive and deep analysis. Naturally, I approve of this theme “If a product is safe enough to be sold in Lisbon, it should be safe enough for Berlin.” Not the usual fare, read the whole thing.
More From Less: Optimizing Vaccine Doses
During COVID, I argued strongly that we should cut the Moderna dose in order to expand supply. In a paper co-authored with Witold Więcek, Michael Kremer and others, we showed that a half dose of Moderna was more effective than a full dose of AstraZenecs and that doubling the effective Moderna supply could have saved many lives.
It’s not just about COVID. My co-author on the COVID paper, Witold Więcek, has found other examples where a failure to run dose optimization trials cost lives:
Take the human papillomavirus (HPV) vaccine. For years after its introduction, countries administered it as a three-dose series. Then additional evidence emerged; eventually, a single dose proved to be non-inferior. This policy shift, driven by updated World Health Organization (WHO) guidance, has been a game-changer—massively reducing delivery costs while expanding coverage in low- and middle-income countries (LMICs). But it took 16 years from regulatory approval to WHO recommendation. Had this change been implemented just five years earlier, the paper estimates that 150,000 lives could have been saved.
Knowing the potential for dose optimization should encourage us to take a closer look at what we can do now. Więcek points to two high-opportunity projects:
- The pneumococcal conjugate vaccine (PCV) is already Gavi’s top cost driver, consuming $1 billion of its 2026–2030 budget. But new WHO SAGE guidance, from March 2025, suggests that in countries with consistently high coverage (≥80–90 percent over five years), either one of three shots could be dropped, or each of the three doses can be lowered to 40 percent of the standard dose. While implementation requires sufficient epidemiological surveillance, its cost would be offset by significant savings in vaccine costs: a retrospective analysis suggests that for the 2020–25 period this approach could have led to as much as $250 million in savings.
- New tuberculosis vaccines, currently in phase 2–3 trials, are another high-impact example. Given initial promising results, a future vaccine could prove highly effective, but may also become a significant cost driver for countries and/or Gavi—and optimization may prove highly beneficial both in terms of health and economic value.
Witold’s new paper is here and here is excellent summary blog post from which I have drawn.
Addendum: See also my paper on Bayesian Dose Optimization Trials and from Mike Doherty Particles that enhance mRNA delivery could reduce vaccine dosage and costs.
Creative Stagnation

Legislation requiring cars and trucks, including electric vehicles, to have AM radios easily cleared a House committee Wednesday, although it could run into opposition going forward.
H.R. 979, the “AM Radio for Every Vehicle Act,” would require the Department of Transportation to enforce the mandate through a rulemaking. It passed the Energy and Commerce Committee by a 50-1 vote. Rep. Jay Obernolte (R-Calif.) was the only “no.”
What’s next—mandating 8-track players in every car? Fax machines in every home? Floppy disks in every laptop? If Congress actually cared about emergency communication, it would strengthen cellular networks, not cling to obsolete technology. Congress is a den of old busybodies.
Hat tip: Nick Gillespie.
Addendum: If AM radio is so valuable for emergencies then the market will provide or you could, you know, put an AM radio in your glove box. No need for a mandate. We already have FM, broadcast TV, cable, satellite, cell, and Wireless Emergency Alerts; resilience can be met without specifying AM hardware.
Here Comes the Sun—If We Let It: Cutting Tariffs and Red Tape for Rooftop Solar
Australia has so much rooftop solar power that some states are offering free electricity during peak hours:
TechCrunch: For years, Australians have been been installing solar panels at a rapid clip. Now that investment is paying off.
The Australian government announced this week that electricity customers in three states will get free electricity for up to three hours per day starting in July 2026.
Solar power has boomed in Australia in recent years. Rooftop solar installations cost about $840 (U.S.) per kilowatt of capacity before rebates, about a third of what U.S. households pay. As a result, more than one in three Australian homes have solar panels on their roof.
Why is rooftop solar adoption in the U.S. lagging behind Australia, Europe, and much of Asia? Australia has roughly as many rooftop installations as the entire United States, despite having less than a tenth of its population.
First, tariffs. U.S. tariffs on imported solar panels mean American buyers pay double to triple the global market rate.
Second, permits. The U.S. permitting process is slow, fragmented, and expensive. In Australia, no permit is required for a standard installation—you simply notify the distributor and have an accredited installer certify safety. In Australia, a rooftop solar panel is treated like an appliance; in the U.S., it’s treated like a mini power plant. Germany takes a similar approach to Australia, with national standards and an “as-of-right” presumption for rooftop solar that removes red tape.
By contrast, the U.S. system involves multiple layers of approval—building and electrical permits, several inspections, and a Permission-to-Operate from the local utility, which may not be eager to speed things up just to lose your business. Moreover, each of thousands of jurisdictions has different requirements, creating long delays and high costs.
High costs suppress adoption, limiting economies of scale and forcing installers to spend more on sales than installation. Yet Australia and Germany are not so different from the United States—they simply made solar easy. If the U.S. eliminated tariffs, standardized/nationalized rules, and accelerated approvals, rooftop solar would take off, costs would fall, and innovation would follow.
The benefits extend beyond cheaper power. Distributed rooftop generation makes the grid more resilient. Streamlining solar policy would thus cut energy costs, strengthen protection against disasters and disruptions, and speed the transition to a future with more abundant and cleaner power.
The MR Podcast: Our Favorite Models, Session 3: Compensating Differentials and Selective Incentives
On The Marginal Revolution Podcast this week, Tyler and I discuss compensating differentials and Olsonian selective incentives. Here’s one bit:
If you think about the gender wage gap, it’s sometimes said that women earn—it varies—80 cents for every dollar that a man earns. That doesn’t control for anything. Once you control for education and skill and so forth, this gets smaller. Then you also have to control for these quite difficult, elusive sometimes, job amenities. Claudia Goldin, for example, has pointed out that men are much more willing to take jobs requiring inflexible hours.
COWEN: And longer hours, too.
TABARROK: Longer hours and inflexible hours, where your hours are less under your control. That’s what I mean by inflexible. For example, in one study of train and bus drivers, the train and bus drivers are paid equally by gender. There’s no differences whatsoever in what they’re paid on an hourly basis. It turns out that the male drivers, their wages, their returns are much higher because they take a lot more overtime. They take 83% more overtime than their female colleagues. They’re much more likely to accept an overtime shift, which pays time and a half. The male workers also take fewer unpaid hours off. The male salaries on a yearly basis end up being higher, even though males and females are paid equally.
Now, you can roll this back and say that’s because of the unfair demands on women of childcare or something like that, but it’s not a market discrimination. It’s not market discrimination. It’s a compensating differential. Males earn more because they’re more willing to take the inflexible overtime hours and so forth.
One of the most interesting ones is that Uber drivers, male drivers earn a little bit more. Now, obviously, there’s no gender difference whatsoever in how the drivers are paid. It just turns out that male drivers just drive a little bit faster.
COWEN: I’ve noticed this, by the way, when I take Ubers.
TABARROK: On an annual basis, they make about 7% more. Now, again, it’s not entirely obvious that this is even better for the male drivers. Maybe they’re taking a little bit more risk. Maybe they’re a little bit more likely to get into an accident as well.
….COWEN: …Someone gets the short end of the stick. Not only women, but maybe women on average would be more likely to suffer.
TABARROK: I’m not sure it’s the short end of the stick, though I agree with increasing returns, that the people who work longer hours will also earn higher salaries and maybe have plush offices and so forth. Let me put it this way. One of the things which I think the feminism story sometimes gets a little bit wrong is to actually underestimate the value that women get, and that men can get as well, of childcare, of looking after kids, of spending more time at home, or spending more time doing childcare. That can be extremely valuable. At the end of life, who writes on their tombstone, “I wish I could have worked more”?
COWEN: You’re looking at one.
TABARROK: Present company excepted.
Here’s the episode. Subscribe now to take a small step toward a much better world: Apple Podcasts | Spotify | YouTube.
How Cultural Diversity Drives Innovation
It is hardly possible to overrate the value…of placing human beings in contact with persons dissimilar to themselves, and with modes of thought and action unlike those with which they are familiar….Such communication has always been, and is peculiarly in the present age, one of the primary sources of progress.
Mill had in mind the civilizing force of commerce but the idea is far more general. My colleague Jonathan Schulz with Max Posch and Joe Henrich have a novel and important test of the idea in a paper forthcoming in the JPE: How Cultural Diversity Drives Innovation (WP; SSRN). They show that the more diverse a county, as measured by surnames, the more ideas and the more novel ideas were patented in that county.
We show that innovation in U.S. counties from 1850 to 1940 was propelled by shifts in the local social structure, as captured using the diversity of surnames. Leveraging quasi-random variation in counties’ surnames—stemming from the interplay between historical fluctuations in immigration and local factors that attract immigrants—we find that more diverse social structures increased both the quantity and quality of patents, likely because they spurred interactions among individuals with different skills and perspectives. The results suggest that the free flow of information between diverse minds drives innovation and contributed to the emergence of the U.S. as a global innovation hub.
David Brooks on the New Right
Excellent David Brooks column on how the right has adopted the theories and tools of the left:
As so many have noted, MAGA is identity politics for white people. It turns out that identity politics is more effective when your group is in the majority.
…Last year, a writer named James Lindsay cribbed language from “The Communist Manifesto,” changed its valences so that they were right wing and submitted it to a conservative publication called The American Reformer. The editors, unaware of the provenance, were happy to print it. When the hoax was revealed, they were still happy! The right is now eager to embrace the ideas that led to tyranny, the gulag and Mao’s Cultural Revolution. Interestingly, the right didn’t take the leftist ideas that were intended to build something; they took just the ideas intended to destroy.
Read the whole thing.
Time to Privatize U.S. Air Traffic Control—Copy Canada’s Model
Yesterday, the FAA grounded flights at Reagan (DCA) because there weren’t enough air traffic controllers. By mid‑afternoon, thousands of flights were delayed nationwide. The same thing is happening at major airports across the country.
The proximate cause is that the FAA is short about ~3,500 controllers, forcing the rest to work mandatory overtime, six days a week, and now, during the shutdown, sometimes without pay! The more fundamental problem is that we have a poorly incentivized system. It’s absurd that a mission‑critical service is financed by annual appropriations subject to political failure. We need to remove the politics.
Canada fixed this in 1996 by spinning off air navigation services to NAV CANADA, a private, non‑profit utility funded by user fees, not taxes. Safety regulation stayed with the government; operations moved to a professionally governed, bond‑financed utility with multi‑year budgets. NAV Canada has been instrumental in moving Canada to more accurate and safer satellite-based navigation, rather than relying on ground-based radar as in the US.
NAV CANADA – in conjunction with the United Kingdom’s NATS – was the first in the world to deploy space-based ADS-B, by implementing it in 2019 over the North Atlantic, the world’s busiest oceanic airspace.
NAV CANADA was also the first air navigation service provider worldwide to implement space-based ADS-B in its domestic airspace.
Meanwhile, America’s NextGen has delivered a fraction of promised benefits, years late and over budget. As the Office of Inspector General reports:
Lengthy delays and cost growth have been a recurring feature of FAA’s modernization efforts through the course of NextGen’s over 20-year lifespan. FAA faced significant challenges throughout NextGen’s development and implementation phases that resulted in delaying or reducing benefits and delivering fewer capabilities than expected. While NextGen programs and capabilities have delivered some benefits in the form of more efficient air traffic management and reduced flight delays and airline operating costs, as of December 2024, FAA had achieved only about 16 percent of NextGen’s total expected benefits.
Airlines bleed money when planes idle, gates clog, and crews time out. The airlines have every reason to demand reliability, capacity, and modernization—Congress does not. Thus, fund air traffic control with user fees paid by those who depend on performance. Put the airline executives on the board of the non-profit, as in Canada. Give them the power to tax themselves to benefit themselves.
Align power with incentives and performance will follow.
The Game Theory of House of Dynamite
In the comments to yesterday’s review of House of Dynamite, some people balked at the movie’s central premise: that the U.S. has to decide—immediately—whether to launch a retaliatory nuclear strike. “Why not wait?” they asked. “Why not take a few days, even a few months, to figure out who actually fired the missile?”
That question even came up at GMU lunch, so it’s worth explaining why the time pressure is realistic. No real spoilers.
The U.S. doesn’t know whether the missile came from China, Russia, or North Korea and that seems to weigh in favor of waiting and gathering evidence. But here’s the problem: Russia, China, and North Korea don’t know what the U.S. knows. Suppose Russia thinks the U.S. believes Russia launched the strike. Then Russia expects retaliation. Expecting retaliation makes it rational for Russia to attack first. So Russia mobilizes.
The mobilization convinces the U.S. that Russia is preparing to attack—so now it’s rational for the U.S. to strike first. Which, of course, confirms Russia’s fears and pushes them closer to launching.
Even if the U.S. doesn’t actually think Russia fired the missile, it might still attack. Why? Because it believes that Russia believes the U.S. believes Russia did.
In this belief spiral, delay brings doom not clarity. In the film, Jake Baerington tries to break the doom loop but the logic is strong and amplified by speed and fear. Breaking the loop isn’t impossible, but as the movie suggests, it requires an act that cuts against immediate self-interest.
What to Watch
A House of Dynamite (Netflix) is an expertly crafted political thriller about living 18 minutes from nuclear annihilation. Directed by Kathryn Bigelow, it shares thematic DNA with two of her previous films, The Hurt Locker and Zero Dark Thirty. (Bigelow also directed the cult classic Point Break and the underrated Strange Days). The film tightens the tension in the first 18 minutes, releases it just enough to breathe, then resets and winds you up again—and then again. There is no climax. That frustrates some viewers, but the ending makes the point: the film is fiction but we are the ones living in a house of dynamite. Nuclear war is underrated as a problem–see previous MR posts. The film is technically and politically well researched, which is one reason the Pentagon is trying to pushback on some figures. If HOD is to be charged with a lack of realism, it’s in the competency of the within 18-minute response (although there are some excellent phone scenes.)
Springsteen: Deliver Me from Nowhere isn’t a conventional rock biopic. It focuses on the making of Nebraska, Springsteen’s bleakest and most intimate album—a solo acoustic recorded at his home in New Jersey on a cassette. Nebraska’s songs portray not the merely unlucky, but the damned: people who drag others down with them.
I saw her standing on her front lawn
Just a-twirling her baton
Me and her went for a ride, sir
And ten innocent people died…I can’t say that I’m sorry
For the things that we done
At least for a little while, sir
Me and her, we had us some fun
Springsteen was depressed at the time. The film has three love stories, the first and least important is between Springsteen and his then girlfriend. The second is Springsteen’s relationship with his troubled father. The third is with his manager, Jon Landau. We should all be so lucky to have someone who loves us as much as Landau loved Springsteen.
Jeremy Allen White, as Springsteen, gives a strong performance; in some shots he looks uncannily like him. He sings most of the songs himself and excels on the Nebraska material, though he can’t match Springsteen’s power and electricity on the brief E Street Band sequences. Jeremy Strong is excellent as Landau.
I liked Deliver Me from Nowhere, but it doesn’t demand a big screen, you can watch at home.
It’s not a movie, but for my money Wings for Wheels: The Making of “Born to Run”, included with the 30th-anniversary edition of BTR, remains the definitive portrait of Springsteen at work. It shows Springsteen driving the E Street Band through take after take, unrelenting and exhausting, in pursuit of the sound in his head—a great study in creative obsession. Pairs well with the very different process documented in Peter Jackson’s Get Back.
Privatizing Law Enforcement: The Economics of Whistleblowing
The False Claims Act lets whistleblowers sue private firms on behalf of the federal government. In exchange for uncovering fraud and bringing the case, whistleblowers can receive up to 30% of any recovered funds. My work on bounty hunters made me appreciate the idea of private incentives in the service of public goals but a recent paper by Jetson Leder-Luis quantifies the value of the False Claims Act.
Leder-Luis looks at Medicare fraud. Because the government depends heavily on medical providers to accurately report the services they deliver, Medicare is vulnerable to misbilling. It helps, therefore, to have an insider willing to spill the beans. Moreover, the amounts involved are very large giving whistleblowers strong incentives. One notable case, for example, involved manipulating cost reports in order to receive extra payments for “outliers,” unusually expensive patients.
On November 4, 2002, Tenet Healthcare, a large investor-owned hospital company, was sued under the False Claims Act for manipulating its cost reports in order to illicitly receive additional outlier payments. This lawsuit was settled in June 2006, with Tenet paying $788 million to resolve these allegations without admission of guilt.
The savings from the defendants alone were significant but Leder-Luis looks for the deterrent effect—the reduction in fraud beyond the firms directly penalized. He finds that after the Tenet case, outlier payments fell sharply relative to comparable categories, even at hospitals that were never sued.
Tenet settled the outlier case for $788 million, but outlier payments were around $500 million per month at the time of the lawsuit and declined by more than half following litigation. This indicates that outlier payment manipulation was widespread… for controls, I consider the other broad types of payments made by Medicare that are of comparable scale, including durable medical equipment, home health care, hospice care, nursing care, and disproportionate share payments for hospitals that serve many low-income patients.
…the five-year discounted deterrence measurement for the outlier payments computed is $17.46 billion, which is roughly nineten times the total settlement value of the outlier whistleblowing lawsuits of $923 million.
[Overall]…I analyze four case studies for which whistleblowers recovered $1.9 billion in federal funds. I estimate that these lawsuits generated $18.9 billion in specific deterrence effects. In contrast, public costs for all lawsuits filed in 2018 amounted to less than $108.5 million, and total whistleblower payouts for all cases since 1986 have totaled $4.29 billion. Just the few large whistleblowing cases I analyze have more than paid for the public costs of the entire whistleblowing program over its life span, indicating a very high return on investment to the FCA.
As an aside, Leder-Luis uses synthetic control but allows the controls to come from different time periods. I’m less enthused by the method because it introduces another free parameter but given the large gains at small cost from the False Claims Act, I don’t doubt the conclusion:
The results of this analysis suggest that privatization is a highly effective way to combat fraud. Whistleblowing and private enforcement have strong deterrence effects and relatively low costs, overcoming the limited incentives for government-conducted antifraud enforcement. A major benefit of the False Claims Act is not just the information provided by the whistleblower but also the profit motive it provides for whistleblowers to root out fraud.